Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Anti-CD11a enters phase I/II study in kidney transplant patients

April 4, 2000

Phase III study of ETEC vaccine does not meet primary clinical endpoint

April 3, 2000

Immunostimulatory sequence designed by Dynavax reduces HSV-2 severity

March 30, 2000

Development and use of gene-based multivalent malaria vaccine

March 28, 2000

Glaxo Wellcome expands DNA vaccine program with PowderJect

March 28, 2000

Siga acquires Chlamydia vaccine technology from Oregon State University

March 27, 2000

Vasogen cleared to proceed with clinical trial of VAS-981 in leukemia patients

March 24, 2000

IND filed with FDA for ISAtx-247

March 23, 2000

Effects of TAK-603 on cytokine production reported at Japanese congress

March 22, 2000

Medinox's NO neutralizer prevents transplant rejection in preclinical study

March 21, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...